PARP inhibitory [Poly(ADP-ribose) Polymerase Inhibitors]

tematický
185
Termíny

inhibitor PARP
inhibitory PARP
inhibitory poly-ADP-ribosylace
inhibitory poly(ADP-riboza) polymerázy
PARP inhibitor

 

Inhibitors of Poly(ADP-ribose) Polymerase
Inhibitors of Poly(ADP-ribose) Polymerases
PARP Inhibitor
PARP Inhibitors
Poly(ADP-Ribose) Polymerase Inhibitor
Poly(ADP-ribosylation) Inhibitor
Poly(ADP-ribosylation) Inhibitors

Perzistentní odkaz   https://www.medvik.cz/link/D000067856
Definice

Chemické látky a léky, které inhibují účinek poly(ADP-ribóza)-polymeráz.

Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.

DUI
D000067856 MeSH Prohlížeč
CUI
M000601132
Historická pozn.
2016
Veřejná pozn.
2016

D Chemikálie a léčiva
D27.505.519.389 inhibitory enzymů 873
D27.505.519.389.092 inhibitory adenosindeaminasy 6
D27.505.519.389.108 inhibitory adenylylcyklasy 14
D27.505.519.389.174 inhibitory kalcineurinu 122
D27.505.519.389.200 inhibitory karboanhydras 59
D27.505.519.389.275 cholinesterasové inhibitory 966
D27.505.519.389.310 inhibitory cyklooxygenasy 454
D27.505.519.389.335 inhibitory cytochromu P450 93
D27.505.519.389.350 antagonisté kyseliny listové 67
D27.505.519.389.360 inhibitory histondeacetylas 110
D27.505.519.389.370 statiny 1 832
D27.505.519.389.375 inhibitory integrasy 4
D27.505.519.389.400 inhibitory beta-laktamasy 74
D27.505.519.389.480 inhibitory lipoxygenas 51
D27.505.519.389.616 inhibitory MAO 155
D27.505.519.389.735 inhibitory fosfodiesteras 405
D27.505.519.389.737 inhibitory fosfolipasy A2 9
D27.505.519.389.739 PARP inhibitory 185
D27.505.519.389.740 inhibitory prolylhydroxylas 3
D27.505.519.389.745 inhibitory proteas 272
D27.505.519.389.755 inhibitory proteinkinas 1 362
D27.505.519.389.760 inhibitory syntézy proteinů 37
D27.505.519.389.848 inhibitory protonové pumpy 488
D27.505.519.389.870 inhibitory syntézy steroidů 1
D27.505.519.389.892 inhibitory topoisomeras 7
D27.505.519.389.936 rozpřahující látky 24
D27.505.954.248 protinádorové látky 7 709
D27.505.954.248.025 inhibitory angiogeneze 630
D27.505.954.248.106 protinádorová antibiotika 251
D27.505.954.248.125 antikarcinogenní látky 119
D27.505.954.248.144 protinádorové antimetabolity 189
D27.505.954.248.147 antimitotika 13
D27.505.954.248.150 alkylační protinádorové látky 110
D27.505.954.248.179 fytogenní protinádorové látky 262
D27.505.954.248.538 mTOR inhibitory 17
D27.505.954.248.589 myeloablativní agonisté 23
D27.505.954.248.692 PARP inhibitory 185
D27.505.954.248.794 inhibitory topoisomeras 7